Awareness of bone strength in patients with neuromuscular disorders: ERN EURO-NMD clinician survey and European patient survey
Language English Country Netherlands Media print-electronic
Document type Journal Article
PubMed
40121805
DOI
10.1016/j.jns.2025.123420
PII: S0022-510X(25)00037-1
Knihovny.cz E-resources
- Keywords
- Bone health, Bone strength, Fracture, Immobilization, Management, Neuromuscular disorders,
- MeSH
- Adult MeSH
- Bone Density * physiology MeSH
- Middle Aged MeSH
- Humans MeSH
- Neuromuscular Diseases * complications physiopathology therapy epidemiology MeSH
- Surveys and Questionnaires MeSH
- Aged MeSH
- Awareness * MeSH
- Health Knowledge, Attitudes, Practice * MeSH
- Health Personnel MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Europe epidemiology MeSH
Bone strength is reduced In various neuromuscular disorders (NMDs). We aimed to assess the awareness and practice of bone strength management in NDMs among clinicians and patients. We performed two online surveys; among health care providers (HCPs) of the European Reference Network for Neuromuscular Disorders (ERN EURO-NMD) and among patients. The survey among 52 HCPs showed that awareness of potentially impaired bone strength in people with NMDs was reasonable to good: the vast majority of HCPs asked often or almost always about bone fractures during history-taking (81 %). Bone strength was less often assessed: often or almost always at diagnosis (50 %) and at follow-up (58 %). Medical training on this topic was considered poor to very poor in 50 % of HCPs. Prevention and treatment of reduced bone strength was variable and multidisciplinary care was sub-optimal. The survey among 581 patients provided important additional insights. Many patients were followed-up outside ERN EURO-NMD centers and treatment was variable. These parallel surveys provided a broad view on the awareness and management of bone strength in people with NMDs. The findings are expected to increase the appreciation of this important aspect of NMD care, and direct future research foci and care guidelines.
Department of Neurology Amsterdam University Medical Centre the Netherlands
Diagnosegruppe Myositis Germany
Lt gen Van Heutszlaan 63743 JN Baarn The Netherlands
Unité de Morphologie Neuromusculaire Institut de Myologie Paris France
References provided by Crossref.org